ㄧ般內科 實 證 期 刊 閱 讀 報 告 EBM-style Journal Reading. 報告人：蔡杰璋 Email: [email protected] 指導臨床教師：何昌益 日期： 2009/4/30 地點：ㄧ般內科醫研室. Clinical Scenario （臨床情境）.
ㄧ般內科實 證 期 刊 閱 讀 報 告EBM-style Journal Reading
報告人：蔡杰璋 Email: [email protected]
Type of Question: Therapy
trials assessing antithrombotic therapies for preventing stroke in patients with nonvalvular atrial fibrillation.
with atrial fibrillation, yet many patients do not benefit
substantially from anticoagulation. Large benefits of
adjusted-dose warfarin accrue to selected high-risk patients with atrial fibrillation, while low-risk patients who do not benefit importantly from anticoagulation over aspirin can be identified.
Clinical bottom line 臨床決策底線
Stroke risk stratification to identify high-risk patients with atrial fibrillation who warrant lifelong anticoagulation has been investigated by the SPAF Investigators
Prevention of stroke in patients with nonvalvular atrial fibrillation.Hart RG, Sherman DG, Easton JD, Cairns JA.University of Texas Health Science Center, San Antonio 78284-7883
Stroke risk stratification to identify high-risk patients with atrial fibrillation who warrant lifelong anticoagulation